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Abstract 
Background: Little is known about trajectories of PTSD symptoms across the peripartum period in 
women with trauma histories, specifically those who met lifetime PTSD diagnoses prior to 
pregnancy. The present study seeks to identify factors that influence PTSD symptom load across 
pregnancy and early postpartum, and study its impact on postpartum adaptation. Method: The 
current study is a secondary analysis on pregnant women with a Lifetime PTSD diagnosis (N=319) 
derived from a larger community sample who were interviewed twice across pregnancy (28 and 35 
weeks) and again at 6 weeks postpartum, assessing socio-economic risks, mental health, past and 
ongoing trauma exposure, and adaptation to postpartum.  Results:  Using trajectory analysis, first 
we examined the natural course of PTSD symptoms based on patterns across peripartum, and found 
4 distinct trajectory groups. Secondly, we explored factors (demographic, historical, and gestational) 
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that shape the PTSD symptom trajectories, and examined the impact of trajectory membership on 
maternal postpartum adaptation. We found that child abuse history, demographic risk, and lifetime 
PTSD symptom count increased pregnancy-onset PTSD risk, whereas gestational PTSD symptom 
trajectory was best predicted by interim trauma and labor anxiety. Women with the greatest PTSD 
symptom rise during pregnancy were most likely to suffer postpartum depression and reported 
greatest bonding impairment with their infants at 6 weeks postpartum.  Conclusions: Screening for 
modifiable risks (interpersonal trauma exposure and labor anxiety) and /or PTSD symptom load 
during pregnancy appears critical to promote maternal wellbeing.  
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Introduction 
Post-traumatic stress disorder (PTSD) is common following trauma, and low-income and 
minority women are at particularly high risk for both exposure to trauma 
1,2
 and development of PTSD 
3–5
. Prevalence rates among women ranges from 10-20% for lifetime PTSD and around 5% 
6,7
 for 
current PTSD. With growing awareness of cross-generational transmission of risk for 
psychopathology there is increasing attention to PTSD during the peripartum (i.e., pregnancy and first 
year postpartum). PTSD rates are up to 24% during pregnancy for high-risk women who are racial 
minorities, teens, less educated or poor 
8
.  
Maternal PTSD in pregnancy, even after controlling for demographic factors, increases the 
odds for poor pregnancy and birthing outcomes, such as ectopic pregnancy, miscarriage, preterm 
labor 
8
, and low birth weight
9
. Furthermore, maternal gestational stress, trauma, and PTSD adversely 
impact fetal functional and structural brain development. Maternal stress hormones during pregnancy 
modulate fetal stress hormone reactivity 
10
 and babies of “stressed” mothers are likely to show altered 
HPA axis functioning of basal cortisol
11,12
 and stress reactivity 
13,14
.  Additionally, animal work 
demonstrates a link between prenatal stress exposure and alterations in specific brain structures 
15
. 
Although evidence from humans is still sparse in this area 
16
, there is initial evidence that prenatal 









, and adult disease 27.   
The peripartum period may be experienced as stressful and/or traumatic, particularly for 
women with past trauma histories 28. PTSD often exhibits chronic course with fluctuating symptom 
severity that can be exacerbated by re-exposure to traumatic/stressful events 
29,30.  Women with prior 
reproductive trauma 31 or prior interpersonal trauma history, especially childhood maltreatment, 
may have increased risk for re-emergence of PTSD symptoms 29,32,33. Onoye and colleagues 34 
reported that community-recruited women peaked with PTSD symptoms in late gestation if they 
were exposed to trauma during pregnancy.   
Thus, reducing the prevalence of maternal trauma exposure and the incidence or severity of 
PTSD during pregnancy has important public health implications, for both the mother and child. 
Systematic screening for trauma exposure and signs of PTSD relapse early in gestation may reduce 
risk for relapse to clinical PTSD diagnosis during the peripartum, and subsequently reduce risks for 
adverse outcomes in both mother and baby 11,35,36.  Women with PTSD symptoms in pregnancy 
might be in critical needs for services 
37
 in order to facilitate a healthy course of pregnancy and to 
promote adequate fetal growth and development. 
Although cumulatively prior research has demonstrated clinically significant impact of PTSD 
on peripartum women37 and their infants9–12, there are no longitudinal studies of PTSD across 
peripartum in women at greatest risk.  Therefore, the primary goal of this study is to examine the 
natural course of PTSD symptoms across the peripartum period in women with heightened 
vulnerability for illness or relapse (i.e., current/lifetime PTSD diagnoses due to interpersonal 
violence) 30. Based on prior works, we hypothesize that the majority of such vulnerable women will 
experience an increase in PTSD symptoms during the peripartum period28,31–34.  Additionally, 
although research shows that past trauma 28, poverty 8, concurrent stress/trauma34, history of 
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PTSD30, and pregnancy28 itself can increase risk for PTSD, we have no actual data to model the course 
of PTSD symptoms across pregnancy and early postpartum in these vulnerable women. Therefore, 
our secondary research question is to identify risk factors (demographic, historical, gestational) that 
shape the natural course of peripartum PTSD symptom trajectories.  We hypothesize that more risk 
factors, especially experiencing trauma, will be associated with a greater increase in PTSD 
symptoms.  Finally, our third research question will examine the impact of peripartum PTSD 
symptom trajectories on women’s postpartum functioning in other domains relevant to motherhood 
(i.e., depression, subjective bonding with infant, breastfeeding).   
This study is the first to longitudinally follow women with PTSD risk across gestation and 
early postpartum with the goals of describing naturalistic PTSD symptom patterns, identifying risk 
factors, and examining consequences of these PTSD patterns on postpartum adaptation.  We aim to 
shed light on those vulnerable for and resilient to symptom exacerbation with the hope that findings 
can guide development of more targeted interventions to reduce illness burden and reduce 
transmission of risk to the child.   
Method 
The current study is a secondary analysis from a larger study focused on determining the 
effects of PTSD on childbearing outcomes (i.e., pregnancy health, birth, and postpartum adjustment) 
in a community sample of pregnant women (NIH NR008767; “the Stress, Trauma, Anxiety, and the 
Childbearing Year, STACY project”). Eligible women presenting to antenatal care (>18 years, English 
speaking, expecting their first infant, < 28 weeks completed gestation) were recruited from 2005 to 
2008.  The study oversampled for low SES by recruiting from prenatal clinics of three academic 
health centers, two of which were in an urban area, with one serving 90% women who were 
publically insured.  Women initiating prenatal care in these clinics were invited to participate by 
obstetric nurses and those interested in participating gave contact information and assent to be 
called up by a research survey organization (DataStat, Inc.) for more interviewing over the phone.  
DataStat team was comprised of 13 diverse women who specialized in health-related standardized 
telephone interviews, who conducted all participant interviews averaging 32 minutes each. Ten 
percent of interviews were monitored live by a supervisor. The phone contacts were as follows: at or 
before 28 weeks gestation (wave 1); at 35 weeks gestation (wave 2); and at 6 weeks postpartum 
(wave 3).  Of the 2,689 interested women, 758 were unreachable, 284 were ineligible, 58 declined at 
the start of the first interview, and 8 interviews were interrupted and not completed, leaving a total 
of 1,581 women enrolled in the study. Prior published work shows detailed screening and 
enrollment flow chart on these 1,581 eligible women with complete first interviews at wave 138. 
Among these 1,581 women, 319 (20.2%) had met PTSD diagnosis (lifetime or current), 532 (33.6%) 
were subsyndromal (i.e., had few PTSD symptoms but never had met diagnostic criteria), 380 (24%) 
were trauma-exposed resilient without PTSD, and finally, 350 (22.1%) were healthy controls.  For the 
current study, we selected the subsample of women with heightened risk for PTSD, those who either 
at present or in lifetime had met diagnostic criteria for PTSD (n=319, 20.2% of total sample), with the 
aim to study the course of symptoms among these risk-women across gestation and early 
postpartum (see Table 1). 
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Demographics. Demographics were assessed using the Perinatal Risk Assessment Monitoring 
Survey (PRAMS)39. A score of “1” was assigned for each “risk” (under 21 years, non-White, no 
partner, high school diploma or less, income less than $15,000); scores were summed as a 
cumulative risk index for analyses40. 
Historical and Gestational Characteristics.  The National Women's Study PTSD Module (NWS-
PTSD)41 was utilized for the assessment of both continuous PTSD 17 symptom count and a diagnosis 
based on DSM-IV criteria41. Depression was assessed at wave 1 with the Composite International 
Diagnostic Interview short form (CIDI)42. The Dissociative Experience Scale-Taxonomic Version (DES-
T)43 assessed lifetime status of dissociative experiences commonly associated with PTSD and 
childhood abuse44.  The Life Stressor Checklist-Revised (LSC-R)45 assessed lifetime trauma for 29 
potential trauma exposures.  Three subscales were derived from this checklist including: child abuse 
(5 items), adult abuse (3 items), and non-abuse trauma (21 items).  In wave 2, 13 of the items 
assessed the occurrence of concurrent stress/trauma, the most frequent of which included ‘severe 
financial problems’, ‘family member put in jail’ and ‘care for an ill family member’.  Also at wave 2, 
labor anxiety was assessed using a 5-item subscale of the Childbirth Self-Efficacy Inventory46, social 
support was assessed using the Family APGAR 47, a five-item 5-point scale that measures family 
functioning, and the client’s appraisal of the quality of her maternity care providers was assessed 
using the Health Care Alliance Questionnaire, a 16-item scale adapted from therapeutic alliance 
measurements48.  
Postpartum Adaptation. Using the Postpartum Bonding Questionnaire49, participants self-
rated problematic bonding with their infant and indicated whether they were breastfeeding at wave 
3. Depression was assessed using the Postpartum Depression Screening Scale (PDSS)50 which is more 
detailed and valid in obstetric settings compared to other common screening measures 51.  It 
provides a continuous score (35-175), with a validated cut-off >80 indicating probable depressive 
diagnosis50.  
 
Plan for Analyses 
Missingness.  Prior to analyses addressing the primary research aim, we performed 
imputation of missing data.  First, item-level imputation was done to compensate for a single item 
omission error of a PTSD symptom at wave 2 and 3 using the dissociation score and trauma items 
(Receptive Operative Characteristics curve of .91). Following guidelines52, we also imputed for 
attrition because 42.9% had missing data at wave 2 and 51.1% at wave 3. These rates are consistent 
with methodological studies showing imputation should not yield bias in parameter estimates53–55. 
Attrition analyses found those who completed all three waves of data collection had significantly 
lower cumulative sociodemographic risk than those lost to follow up, but there were no significant 
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differences in PTSD status or outcome variables of interest. We proceeded with the SAS PROC TRAJ 
procedure with a Poisson distribution, an approach that handles random wave nonresponse. Results 
describing the complete dataset (N=319) and a smaller dataset without missing values (n=156) were 
similar.  
Hypothesis testing. To examine the course of PTSD symptoms across peripartum, we 
conducted semiparametric, group-based trajectory analysis56. Conclusions about the best number 
and shape of the trajectory groups are based on the Bayesian Information Criterion (BIC)56, seeking 
the most parsimonious models56.  To examine demographic, historical, and gestational predictors 
(N=319) and postpartum adaptation (n=156) that might explain the distinct PTSD trajectories, we 
utilized two-tailed ANOVAs and chi-square tests, and General Linear Model regressions with manual 
backward steps.  
 
Results 
PTSD symptom trajectory groups  
Posterior probability scores ≥ .80 were calculated to assign each participant to a trajectory 
yielding the optimal number of distinct PTSD trajectories of four, with quadratic shapes (BIC=-2431; 
Figure 1). This means that PTSD symptoms over time were likely to follow a non-linear path for all 
groups; however, the groups meaningfully differed from each other. We identified two groups with 
rapid symptom changes across gestation: a rapidly increasing group (Increase), and a rapidly 
decreasing group (Decrease).  These groups had significantly different starting points in early 
pregnancy, with Increase intercept significantly lower than Decrease (t(173)=-15.54, p <.001). Across 
gestation the trajectories of these 2 groups cross— Increase shows significant rise from T1 to T2 
(t(84)=-10.00, p=.000), whereas Decrease shows significant decline (t(98)=15.85, p=.000).  At 6 
weeks postpartum Increase endpoint is significantly higher than Decrease (t(181)=5.41, p <.001).   
In contrast, the other two trajectory groups show more stable patterns.  One group shows 
constant low PTSD symptoms across pregnancy to 6 weeks postpartum (Low; T1 to T2  t(49)=-.49, 
p=ns, and T2 to T3 (t(49)=-2.19, p=.033). Finally, the remaining trajectory group shows a slow 
significant decline of PTSD symptoms across this time period (T1 to T2 (t(86)=3.93, p=.000); and T2 
to T3  (t(86)=6.45, p=.000), yet remains overall significantly above all other PTSD trajectory groups 
(High).  
PTSD diagnostic rates highlight the clinical significance of these PTSD symptom trajectories 
throughout peripartum (see bottom of Figure 1).  
 
Demographic, historical, and gestational factors by trajectory group 
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First we analyzed demographic and historical predictors to PTSD trajectory groups (Table 2). 
Women in the trajectory groups that showed low PTSD symptom load in early gestation (i.e., Low 
and Increase) were less likely non-White (X2(3, N=318)=44.05, p=.000), poor (F(3, 306)=20.42, 
p=.000), single (X2(3, N=319)=45.30, p=.000), and very young (F(3, 315)=29.75, p=.000), and overall 
had less cumulative risk (F(3, 315)=39.59, p=.000) (< 21 years, < $15,000, <=HS education, non-
White, and not having a partner) compared to women in the other 2 groups (i.e., Decrease and 
High). Not having a high school education (X2(3, N=319)=72.38, p=.000) followed a dose effect in the 
expected direction (Low > Increase > Decrease > High).   
As historical predictors, we tested lifetime PTSD and dissociation symptoms, and lifetime 
trauma exposure. We found that Low and Increase had fewer lifetime PTSD symptoms than 
Decrease and High (F(3, 315)=28.87, p=.000). Moreover, Low experienced significantly less child 
abuse than High (F(3, 315)=3.77, p=.011). Finally, lifetime dissociation scores also differed by group 
(F(3, 315)=4.27, p=.006); Low and  Decrease were similar in dissociation scores, and both had 
significantly lower scores than High.  Lifetime adult abuse and lifetime non-abuse trauma did not 
differentiate group membership. 
 We next explored gestational factors and found anticipatory labor anxiety, social support, 
comorbid depression, and trauma exposure during pregnancy as relevant for symptom course. 
Specifically, we found that Low experienced less labor anxiety compared to all other groups (F(3, 
147)=6.09, p=.001);  and had significantly more social support than High (F(3, 178)=3.48, p=.017). 
Low and Increase also had less comorbid depression compared to Decrease and High (X2(3, 
N=319)=13.43, p=.004). Trauma-exposure differed by group status (F(3, 178)=3.48, p=.017), but this 
time Low and Decrease were less likely to experience trauma compared to Increase and High.  Health 
care alliance did not differentiate group membership.  
 
Post-Hoc Analyses Predicting PTSD symptom crossing patterns   
Intrigued by the crossing pregnancy PTSD trajectory patterns (Increase vs Decrease), we 
investigated predictors of these patterns, using for each as contrast the group with complimentary 
starting point. .We found as predictors for Increase (compared to Low) having more stressors during 
pregnancy (β=1.448, p=.013) and more labor anxiety (β=.274, p=.015) (X2(3, N=72)=16.49, p=.000; 
Nagelkerke R2=.281). By contrast, predictors for Decrease (compared to High) were less pregnancy 
stressors (β=1.307, p=.016) and less lifetime PTSD symptoms (β=.376, p=.001) (X2(3, N=79)=25.18, 
p=.000; Nagelkerke R2=.364).   
 
Trajectory group impact on postpartum adaptation 
PTSD trajectory group membership, rather than initial baseline PTSD status, was significantly 
associated with postpartum adaptation (Table 3).  Women across the PTSD trajectory groups 
differed on 6 weeks postpartum depression (X2(3, N=156)=12.17, p=.007), with Increase group 
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showing greatest prevalence of major depression (52.3%), followed by Decrease and High (48.4% 
and 41.7%, respectively), and then Low (15.2%). Results for bonding impairment paralleled 
depression findings (F(3, 152)=6.08, p=.001), such that Increase mothers reported highest bonding 
problems with their infants compared to all other groups. Low rates of breastfeeding at 6 weeks 
postpartum were associated with mothers’ PTSD symptoms in early pregnancy, but not concurrent 
PTSD (F(3, 155)=15.843, p=.001).  
 
Discussion 
In this secondary data analysis paper utilizing a sample of pregnant community women with 
PTSD risk, we aimed to examine naturalistically occurring patterns of PTSD symptoms across 
gestation and early postpartum (i.e., peripartum) , and relate symptom occurrence to. presence or 
absence of various demographic, historical, and gestational factors. We found four distinct patterns 
of PTSD symptoms across peripartum. We had proposed, that women with PTSD risk based on 
lifetime/current PTSD diagnoses such as those in our sample, would all increase in PTSD symptoms 
across gestation. However, in contrast to our primary hypothesis, only one group (26% of sample) 
significantly increased in PTSD symptoms over peripartum.  This was surprising and unexpected.  
Moreover, the majority of women in our sample (58%) started with high PTSD rates, and these 
women all significantly decreased in symptom load throughout peripartum. We identified, not 
surprisingly, several risk factors (i.e., current/lifetime PTSD symptoms, history of child abuse, 
demographic risk) associated with higher PTSD symptoms at the early pregnancy starting point.  
Furthermore, variation in women’s PTSD trajectories across peripartum was best predicted by their 
experience of pregnancy stress/trauma exposure, labor anxiety, and lifetime PTSD symptoms; 
confirming our second hypothesis that stress/trauma during pregnancy would be a particularly 
salient predictor for symptom exacerbation. Finally, PTSD trajectory was significantly associated with 
postpartum adjustment such that women whose PTSD symptoms rose during pregnancy were most 
impacted by postpartum depression and subjective bonding impairment with their infant at 6 weeks 
postpartum.  
In contrast with our first hypothesis and despite substantial impairment during early 
pregnancy, the majority of vulnerable women in our cohort did not increase in PTSD symptoms 
during peripartum.  In fact, the two highest-risk groups of women who had started pregnancy with 
high PTSD symptoms (High and Decrease) both dropped in PTSD diagnosis across peripartum by 
almost half, confirming prior work 34 that showed PTSD symptom reduction in postpartum.  We 
speculate that increases in estradiol and progresterone concentrations at the end of pregnancy 57 
may be associated with lower perceived distress and more positive perception of peripartum to 
promote reproduction and offspring care58. This was pronounced in High mothers who reported low 
subjective bonding impairment.  These significant improvements in the High group occurred despite 
these women carrying great historical and psychosocial burden: 50-70% of these High women had 
entered pregnancy with a current PTSD diagnosis, the majority had high lifetime PTSD symptoms, 
childhood abuse exposure, were younger, more likely poor, uneducated, single and of ethnic 
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minority status.  All these risks are in fact associated with greater illness burden in the literature 
(28,59,60,61), thus, it is interesting that PTSD women actually improve in symptom load across 
pregnancy. More research with larger samples and a wider range of potential predictors (e.g., 
physical health complications, factors related to maternity care, mental health treatment, biological 
markers etc) is needed to shed light on this phenomenon. 
Women classified in Decrease dropped dramatically in PTSD diagnoses across pregnancy 
(56.6 % to only 1.8%).  Interestingly, Decrease members shared one similar feature with the Low 
group—only a few experienced stress/trauma during pregnancy.  Based on these findings, we 
propose that excessive stress/trauma exposure during pregnancy is the most salient factor for 
mental health in pregnancy and immediate postpartum, confirming our second hypothesis and prior 
work on the detrimental effects of trauma/stress on maternal perinatal outcomes 8,10,62..  
The women showing the greatest change in risk constellation across gestation were mothers 
in the Increase group; starting with low PTSD symptoms and increasing to high rates of active illness 
in postpartum (PTSD: 23%; MDD: 52%). The predictors for this striking deterioration were 2-fold 
more exposure to stress/trauma during pregnancy, and higher labor–related anxiety compared to 
members in the Low group. This is consistent with past studies finding that interim stress or trauma 
leads to a 2.4-fold increase in PTSD symptoms across pregnancy 34.  
Increase mothers showed highest rates of postpartum mental illness (>50% depression and 
22% PTSD) and reported the highest levels of subjective bonding impairment with their infants. This 
finding is consistent with prior research showing link between postpartum mental illness and poor 
bonding63. While bonding impairment is a mother’s self-perception and open to distortions, prior 
research has show associations to observed parenting 63. Because bonding impairment was 
associated with PTSD trajectory across pregnancy, and not simply the postpartum PTSD symptom 
load alone, our data seem to validate the clinical utility of longitudinal data collection over and 
above cross-sectional data. Interestingly, breastfeeding frequencies were not associated with group 
trajectories, even in Increase mothers, who had high rates of postpartum psychopathology.  Perhaps 
breastfeeding may be more a product of education and other demographic factors64, than driven by 
psychopathology.   
Our findings are a novel contribution to the field as no known past research has considered 
factors related to PTSD symptom trajectories across the perinatal period.  Put together, our results 
highlight the essential need for repeated assessment of symptomology during this time given the 
substantial fluctuation in symptoms. This is relevant for several reasons.  First, it gives a message of 
hope that a current/lifetime diagnosis of PTSD is by no means deterministic of worsening PTSD in the 
perinatal period.  In fact, results indicate that it is more likely than not that PTSD symptoms will 
remain the same or get better during the perinatal period.  Second, it highlights a vulnerable group 
(Increase) and describes factors that providers can identify as heightening risk for symptom 
exacerbation (e.g., pregnancy stressors/trauma, labor-related anxiety, lifetime PTSD load).  
Preventing symptom exacerbation and manifest postpartum illness protects the offspring from the 
detrimental impact of postpartum mental illness on parental capacity 65. Treatment providers could 
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quickly identify (via a few questions/brief screening measures) mothers who are experiencing such 
risk factors and heighten awareness for support, case management and referrals for treatment. 
Lastly, our results identify a modifiable protective factor that promotes resilience in risk women with 
lifetime-PTSD, namely social support (more so than healthcare alliance).  
 
Limitations 
This study selected participants with heightened risk for PTSD who at baseline met either 
lifetime or current diagnostic criteria, thus women’s symptom levels at baseline were high. As such, 
generalizability of the findings from this population to other obstetrics populations and women with 
less baseline risk may be limited. In order to maximize our sample size, we imputed data; this is a 
limitation, which is mitigated by the use of a sophisticated approach and by validation of results of 
the total dataset using the non-imputed data (n=156). It would have benefitted the study if 
measures assessed at only wave 2 were assessed at multiple time points to better understand their 
roles as group determinants. Although we may infer negative child outcomes of mothers with 
subjective impaired bonding and postpartum psychopathology based on the literature, we remain 
cautious in this implication and suggest future research directly investigate this link.  As our study 
was a secondary analysis with limited range of collected variables potential confounding factors 
(e.g., physical health complications etc.) that may influence PTSD risk were unavailable. Lastly, we 
focused on the progression of PTSD, and although the overlap of PTSD with depression was high for 
some groups, for others the link was more distinct.  Future studies could better understand the 
interaction of these two psychopathologies over time. Please note, PTSD diagnosis is based on DSM-
IV66 criteria.  
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 26  6 
Race Caucasian 107 34 
 African American 155 49 
Asian 17 5 
Hispanic 4 1 
Native American 8 3 
Marital Status Married/partnered 164 51 
 Never married/divorced 155 49 
Table 1. Sample Characteristics (N=319) 
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Education  College or greater 144 45 
 High school/GED or less 175 55 
Household Income <$15,000 100 32 
 $15,000-$25,000 56 18 
 $25,000-$50,000 60 19 
 >$50,000 94 30 
Traumatic Events Child Abuse .83 1.05 
 Adult Abuse .50 .76  







Table 2. Demographic, and Historical Characteristics by Trajectory Group (N=319) 
 
 Low (N=49) Increase (N=84) Decrease (N=99) High (N=87) 
 M or % (SD) M or % (SD) M or % (SD) M or % (SD) 
Demographics         
   Ethnicity         
 % Non-White      44.90a         46.40a  77.80b     84.90b  
   Education         
                   % < HS      18.40a      34.50b     65.70c     82.80d  
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Marital Status         
           % No Partner       8.20a    21.40a       36.40b     48.30b  
   Income (1-4) 3.22a (0.96)   2.93a (1.19)    2.20b (1.15)      1.92b      (1.23) 
   Age 29.55a (5.96) 28.38a (6.02)   23.40b (4.43)   22.91b (5.13) 
   Cumulative Risk 
    1.08a (1.53) 1.52a (1.75)     2.91b (1.54)     3.51b (1.31) 
Historical Factors         
   Lifetime PTSD sx 9.78a (2.53) 9.89a (2.48) 10.35a (2.48) 12.81b (2.09) 
   Lifetime   
   Dissociation 
1.80a (3.67) 2.56ab (3.24)  2.15a (3.15) 3.76b (4.37) 
   Child Abuse  0.55a (0.89)   0.77ab (1.03)   0.76ab (0.98) 1.13b (1.17) 
   Adult Abuse  0.47a (0.79) 0.39a (0.74) 0.52a (0.69) 0.61a (0.85) 
   Non Abuse  
   Trauma 
4.00a (2.05) 3.60a (2.08) 3.58a (2.15) 4.10a (2.22) 
Gestational Factors         
% W1 MDD dx 12.2a  59.6b  36.6a  73.7b  
W2 Labor Anxiety 12.11a (2.30) 14.15b (2.72) 13.93b (3.60) 15.26b (2.63) 
W2 Social Support 21.54a (3.23) 20.24ab (3.11) 19.81ab (5.22) 18.44b (4.72) 
W2 Health Care 
Alliance 
68.62a (10.26) 62.52a (12.74) 64.07a (13.09) 64.62a (9.52) 
Note: A different superscript letter indicates groups are significantly different;  
Income categories are as follows: (1) <15k, (2) 15k-25k, (3) 25k-50k, (4) >50k 
Wave 1 <=28weeks 
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Table 3.  Six Week Postpartum Adaptation by Trajectory Group  (n=156) 
 Low  (N=33) Increase (N=44) Decrease (N=48) High (N=31) 
 M or % (SD) M or % (SD) M or % (SD) M or % (SD) 
% MDD dx 15.20a  52.30b  41.70b  48.40b  
% Breastfeeding 75.80a  72.70a  47.90b  36.70b  
Bonding Impairment 19.61ab (6.34) 23.86b (9.68) 17.06a (7.07) 17.87a (8.85) 
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